AVASTIN (BEVACIZUMAB) — FDA Approval BLA125085 (GENENTECH)
AVASTIN (BEVACIZUMAB) — FDA Approval BLA125085 (GENENTECH) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: AVASTIN; Active ingredients: BEVACIZUMAB; Application number: BLA125085.
| Brand name | AVASTIN |
|---|---|
| Active ingredients | BEVACIZUMAB |
| Application number | BLA125085 |
| Sponsor | GENENTECH |
| Dosage form | VIAL |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20040226 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →